In summary, we show that NMT1 is a novel regulator of lysosomal function in cancer cells, and that lysosomal degradation and mTORC1 activation can be simultaneously blocked by NMT inhibitors to limit tumor growth. The gene discussed is NMT1; the disease is cancer.